Friday, February 15, 2013

• Momenta Pharmaceuticals CEO Discusses Q4 2012 Results - Earnings Call Transcriptat Seeking Alpha (Fri, Feb 15)
• Momenta Pharmaceuticals sticks to guidance despite revenue plungeat bizjournals.com (Fri, Feb 15)
• Momenta Pharmaceuticals Earnings: Here’s Why Investors are Happy Nowat Wall St. Cheat Sheet (Fri, Feb 15)
• MOMENTA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements aEDGAR Online (Fri, Feb 15)
• Momenta Pharma stills sees 2013 operating cash use about $90Mtheflyonthewall.com (Fri, Feb 15)

Thursday, February 7, 2013

• MOMENTA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online (Thu, Feb 7)

Monday, February 4, 2013

• 3 Things to Watch at Momenta Pharmaceuticalsat Motley Fool (Mon, Feb 4)

Wednesday, January 9, 2013

• Biotech's a Buy, but Hold Off on HMOs: Fund Managerat CNBC (Wed, Jan 9)

Wednesday, January 2, 2013

• 2013 Should Be Interesting for Multiple Sclerosis Drugsat Motley Fool (Wed, Jan 2)

Thursday, December 6, 2012

• The Worst of 2012: Momenta Pharmaceuticalsat Motley Fool (Thu, Dec 6)

Tuesday, December 4, 2012

• Momenta Pharmaceuticals' Management Presents at Deutsche Bank 2012 dbAccess BioFEST Conference (Transcript)at Seeking Alpha (Tue, Dec 4)

Monday, December 3, 2012

• Momenta Pharmaceuticals Inc. Stock Downgraded (MNTA)at TheStreet (Mon, Dec 3)

Friday, November 30, 2012

• Teva Guides for Disappointmentat Motley Fool (Fri, Nov 30)

Thursday, November 15, 2012

• Momenta Pharmaceuticals' Management Presents at Credit Suisse 2012 Healthcare Conference (Transcript)at Seeking Alpha (Thu, Nov 15)

Wednesday, November 14, 2012

• Momenta Pharmaceuticals' Management Presents at Lazard Capital Markets 9th Annual Healthcare Conference (Transcript)at Seeking Alpha (Wed, Nov 14)

Friday, November 9, 2012

• Visterra lands $13M from Gates Foundation, othersat bizjournals.com (Fri, Nov 9)

Thursday, November 8, 2012

• MOMENTA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online (Thu, Nov 8)
• Momenta Reveals Projections and 2 Stocks Dipping to 52-Week Lowsat Wall St. Cheat Sheet (Thu, Nov 8)

Wednesday, November 7, 2012

• Why Momenta Stalledat Motley Fool (Wed, Nov 7)
• Momenta Pharmaceutical's CEO Discusses Q3 2012 Results - Earnings Call Transcriptat Seeking Alpha (Wed, Nov 7)
• MOMENTA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements aEDGAR Online (Wed, Nov 7)
• Momenta Pharma CEO: Q3 royalty rev from enoxaparin sodium injection disappointstheflyonthewall.com (Wed, Nov 7)

Thursday, November 1, 2012

• Has Baxter International Become the Perfect Stock?at Motley Fool (Thu, Nov 1)

Friday, October 19, 2012

• A Refreshing Outlook - Consensus Reports on Keryx Biopharmaceuticals, Inc. and Momenta Pharmaceuticals, Inc.Marketwired (Fri, Oct 19)

Friday, October 5, 2012

• Has Teva Pharmaceutical Become the Perfect Stock?at Motley Fool (Fri, Oct 5)

Add MNTA News to My Yahoo!